Altria: Q2 Strong Cigarette Trends More Than Offset Other Setbacks (Preview)
Company Update (MO US) (Buy)
Summary
Altria reported strong Q2 results this morning, with EPS growing 12.8% year-on-year, and raised its 2021 EPS growth outlook to 4.5-6%.
The results were helped by inventory movements, which meant Altria's U.S. cigarette shipments actually grew 1.4% from last year.
Excluding inventory, U.S. cigarette volume decline was just 4.5% in Q2, within the historic range and more than offset by strong price/mix.
In Oral Tobacco, Altria is losing share but still growing profits. In IQOS, expansion has been delayed, but this doesn't change our Buy case.
With shares at $47.62, we expect a total return of 65% (17.6% annualized) by 2024 year-end. The Dividend Yield is 7.2%. Buy.
Introduction
Altria released Q2 2021 results this morning. Shares are currently up 0.8% in pre-market trading (as of 8:45 am EST).
We upgraded our rating on Altria stock to Buy in February 2020. Since then shares have gained 11.0% (almost entirely due to dividends), lagging the approx. 35% gain in the S&P 500 significantly.
Tod…